Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
Vandesompele J, Baudis M, De Preter K, Van Roy N, Ambros P, Bown N, Brinkschmidt C, Christiansen H, Combaret V, Lastowska M, Nicholson J, O'Meara A, Plantaz D, Stallings R, Brichard B, Van den Broecke C, De Bie S, De Paepe A, Laureys G, Speleman F.
Vandesompele J, et al.
J Clin Oncol. 2005 Apr 1;23(10):2280-99. doi: 10.1200/JCO.2005.06.104.
J Clin Oncol. 2005.
PMID: 15800319
Free article.